Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.
Axonis Therapeutics has raised $115.0M in total funding. The most recent round was Series A. The last funding was announced in October 2024.
Axonis Therapeutics's investors include Lumira Ventures, Hatteras Venture Partners, Perceptive Advisors, Cormorant Asset Management, Sofinnova Investments.
Axonis Therapeutics is headquartered in Boston, United States.
Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.
Axonis Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Axonis Therapeutics — Funding & Investors." VCBacked, October 30, 2024, https://www.vcbacked.co/company/axonis-therapeutics. Accessed July 20, 2026.
VCBacked. (2024). Axonis Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/axonis-therapeutics
{{cite web |title=Axonis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/axonis-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated